Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,217,192 papers from all fields of science
Search
Sign In
Create Free Account
CBP/beta-catenin Antagonist PRI-724
Known as:
PRI-724
A potent, specific inhibitor of the canonical Wnt signaling pathway in cancer stem cells with potential antineoplastic activity. Wnt signaling…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Macrophages as an Emerging Source of Wnt Ligands: Relevance in Mucosal Integrity
J. Cosin-Roger
,
Mª Dolores Ortiz-Masià
,
M. Barrachina
Frontiers in Immunology
2019
Corpus ID: 202728315
The Wnt signaling pathway is a conserved pathway involved in important cellular processes such as the control of embryonic…
Expand
2019
2019
The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice
H. Okazaki
,
Seidai Sato
,
+14 authors
Y. Nishioka
Experimental Lung Research
2019
Corpus ID: 196349341
Abstract Purpose/Aim of the Study: Wnt/β-catenin signaling was reported to be activated in pulmonary fibrosis, and was focused on…
Expand
2018
2018
Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
Fang Fang
,
Ashley M. VanCleave
,
+7 authors
Jianning Tao
OncoTarget
2018
Corpus ID: 57390215
Aberrant activation of Wnt signaling has been implicated in human osteosarcoma, which may provide a genetic vulnerability that…
Expand
Review
2017
Review
2017
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
M. Katoh
International Journal of Oncology
2017
Corpus ID: 6886218
Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-differentiation, undergo epigenetic…
Expand
Review
2017
Review
2017
Therapeutic Potential of Targeting Wnt/β‐Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
A. Bahrami
,
F. Amerizadeh
,
+6 authors
A. Avan
Journal of Cellular Biochemistry
2017
Corpus ID: 3918648
Wnt/β‐catenin pathway is one of the main/frequent dysregulated pathways in several tumor types, including colon cancer. Aberrant…
Expand
Highly Cited
2017
Highly Cited
2017
Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
Hong-sheng Zhou
,
Hong-sheng Zhou
,
+7 authors
B. Carter
Leukemia
2017
Corpus ID: 23201372
Tyrosine kinase inhibitor (TKI) resistance and progression to blast crisis (BC), both related to persistent β-catenin activation…
Expand
Review
2017
Review
2017
Therapeutic strategies against cancer stem cells in human colorectal cancer
M. Szaryńska
,
Agata Olejniczak
,
J. Kobiela
,
P. Spychalski
,
Z. Kmieć
Oncology Letters
2017
Corpus ID: 2635068
Colorectal cancer (CRC) is the third most frequent malignancy and represents the fourth most common cause of cancer-associated…
Expand
Highly Cited
2015
Highly Cited
2015
Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
Y. Osawa
,
K. Oboki
,
+7 authors
K. Kimura
EBioMedicine
2015
Corpus ID: 15692798
Review
2014
Review
2014
Safely targeting cancer stem cells via selective catenin coactivator antagonism
H. Lenz
,
M. Kahn
Cancer Science
2014
Corpus ID: 14211869
Throughout our life, long‐lived somatic stem cells (SSC) regenerate adult tissues both during homeostatic processes and repair…
Expand
Highly Cited
2013
Highly Cited
2013
A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
A. El-Khoueiry
,
Y. Ning
,
+8 authors
H. Lenz
2013
Corpus ID: 79287608
2501 Background: PRI-724 is a first-in-class modulator of Wnt signaling that inhibits the CREB binding protein and β-catenin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE